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disturbed sleep. 6 The prevalence of HSP is approximately 22%Y23% in the general population of stroke survivors and approximately 54%Y55% among stroke patients in rehabilitation settings. 7 Up to a third of patients with HSP exhibit pain refractory to treatment, 4 a critical problem for those with HSP and for providers who treat survivors of stroke.
The etiology of HSP is unknown. Kalichman and Ratmansky 7 performed a literature review to better understand the underlying mechanism of HSP and the factors contributing to its development. They categorized HSP on the basis of three underlying aspects: impaired motor control (muscle tone changes), soft tissue lesions, and altered peripheral and central nervous activity. They concluded that these factors may present separately, may coexist simultaneously, or may evolve during the rehabilitation period by triggering each other's development. A newer theory is that there is initial injury to the weak shoulder that causes pain, but maladaptive changes in the peripheral and the central nervous system may allow the pain to persist or worsen beyond the initial injury. 8Y11 There is evidence that somatosensory changes may be associated with chronic pain from HSP, 9,10,12Y15 and peripheral and central hypersensitivity have been implicated in the affected shoulder in those with HSP. 9Y11 To date, there have been no studies that have identified widespread hyperalgesia, evidence of central hypersensitivity, in those who experience chronic HSP.
Central hypersensitivity is an enhancement in the function of neurons and circuits in nociceptive pathways that can lead to pain from innocuous stimulation or exaggerated perception of pain from low-level painful stimuli. It is a manifestation of the plasticity of the somatosensory nervous system in response to inflammation and neural injury. 16 Augmentation in pain perception has been shown to exist in tissues near the site of injury (peripheral or central hypersensitivity) as well as in tissues distant to the site of injury (central hypersensitivity). 17 Current measurement methods do not allow for discriminating between peripheral and central hypersensitivity; however, hypersensitivity in nonaffected tissues distal to the injured tissues suggests central hypersensitivity. Central hypersensitivity has been shown to be associated with multiple other chronic pain syndromes, such as neck pain after whiplash injury, 18 fibromyalgia, 19 carpal tunnel syndrome, 20 osteoarthritis, 21 tension-type headache, 22 temporomandibular joint pain, 23 and subacromial impingement syndrome. 24 These studies all showed that patients displayed exaggerated pain perception distal to the site of injury in unaffected, healthy tissues, which suggests the involvement of a central process.
An association of widespread central hypersensitivity and HSP will provide additional insight into potential causes for this condition and may have implications for treatment. One method of indirectly measuring central hypersensitivity is measuring mechanical hyperalgesia through the pressure-pain threshold (PPT). The PPT is the amount of pressure at which a sensation of pressure first changes to pain. Evidence of reduced pain thresholds has been found in those who are affected by chronic pain syndromes. 19,23Y25 The objective of this study was to examine the PPT in tissues near the painful shoulder and in nonaffected, healthy parts of the body in those with chronic HSP compared with a control group of survivors of stroke without chronic pain. The authors hypothesized that PPTs in the nonaffected, distal tissues as well as in local tissues near the site of injury are lower in the subjects with HSP than in the survivors of stroke without HSP, indirectly indicating central hypersensitivity.
MATERIALS AND METHODS

Subjects
This study was approved by the institutional review board of the authors' local institution. The subjects were recruited from an outpatient stroke clinic including the physician and allied health services of an urban, academic hospital. After obtaining informed consent and establishing eligibility, baseline information was collected. The inclusion criteria for those with HSP included the following: (1) shoulder pain at rest, with passive abduction, or with active abduction; (2) 21 yrs or older; (3) duration of shoulder pain of more than 6 mos; (4) severity of shoulder pain of 4 or higher on a 0Y10 scale at its worst in the last week; (5) the pain occurred after stroke or was exacerbated by stroke; and (6) the stroke was unilateral and shoulder pain presented on the opposite side of the brain lesion. The exclusion criteria for those with HSP included the following: (1) evidence of joint or overlying skin infection; (2) any other chronic pain syndrome; (3) previous shoulder surgery (affected limb); and (4) cognitive or communicative impairments that prevent participation such as hemineglect, aphasia, and cognitive impairments. The inclusion criteria for the pain-free subjects who have had a stroke included the following: (1) 21 yrs or older and (2) evidence of a previous stroke. The exclusion criteria included the following: (1) worst pain in the last week of higher than 3 on a 0Y10 scale in any location; (2) pain in a single location for at least 16 days in the last 30 days;
(3) evidence of infection or injury in areas of PPT testing; and (4) cognitive or communicative impairments that prevent participation such as severe hemineglect, aphasia, or cognitive impairments.
PPT Assessment
The PPT is defined as the minimal amount of pressure at which a sense of pressure first changes to pain. 26 Pressure algometry has been shown to reliably evaluate deep somatic tissue sensitivity within and between raters. 27,28 Two assessors obtained PPT measurements in the subjects with HSP and the controls. The assessors underwent training before this study to standardize measurement methods including subject positioning, assessor blinding to pressure reading, and rate of pressure application. PPTs were measured with a handheld Wagner Instruments FDIX pain test algometer (Wagner Instruments, Greenwich, CT) with a 0.785-cm 2 rubber tip by applying pressure at a rate of 1 kg/cm 2 per second 27 at three locations. The subjects were seated with the arms at their sides. A PPT measurement was obtained in the same order for all subjects. The first measurement was at the mid belly of the deltoid of the painful shoulder (or the nondominant deltoid for the controls), followed by areas distant from the painful shoulder, the mid belly of the deltoid muscle of the nonpainful shoulder (or the dominant shoulder for the controls) and the mid belly of the tibialis anterior muscle of the nonpainful side (or the nondominant leg for the controls). The PPT was measured three times per patient on each site, and the mean was calculated and used for analysis.
Statistical Analysis
Differences in the demographic variables between the two groups were analyzed with the W 2 test or Fisher's exact tests for small cell size (G5) for categorical variables. The continuous variables were analyzed with the Wilcoxon's rank-sum test.
The comparisons to detect differences in PPTs were carried out in two ways. First, comparisons were made between the painful side of those with HSP and the dominant side of the control group. In this analysis, specific comparisons were made between the subjects with HSP and the controls at the painful and dominant shoulders, at the nonpainful and nondominant shoulders, and at the tibialis anterior muscle of the nonpainful side and non-dominant sides, respectively. Second, to control for potential differences related to sensory changes caused by the stroke, comparisons were made between those with HSP and the control subjects within the contralesional and ipsilesional sides. In this analysis, the painful contralesional shoulder of those with HSP is compared with the contralesional shoulder of the controls and the nonpainful ipsilesional shoulder of those with HSP is compared with the ipsilesional shoulder of the controls. A comparison between the ipsilesional tibialis anterior muscles of those with HSP and the controls was also conducted.
Differences in the PPT between the groups were analyzed by Wilcoxon's rank-sum test. To estimate the difference in PPTs between those with HSP and the controls while controlling for sex, the authors predicted PPTs from linear regression models with the covariate of sex added to the model. The 95% confidence intervals (CIs) were calculated by bootstrapping the estimates (1000 iterations) and finding the 2.5 and 97.5 percentiles. Because of nonnormality of the distributions of the local deltoid, nonaffected deltoid, and tibialis anterior PPTs, these distributions were transformed to their square root 29 before the regression analysis, and predicted values were back-transformed to the original scale before calculation of PPT differences.
RESULTS
A total of 40 patients (n = 20 HSP; n = 20, stroke without HSP) were enrolled in this study from March through September 2011. Table 1 contains the demographic information collected on the subjects in each group. There was a significant difference between the groups in allocation by sex (75% of women in those with HSP vs. 40% for the controls, P = 0.02). There were no significant differences by age, race/ethnicity, type of stroke, hemorrhagic/ischemic stroke, history of neglect, history of abnormal sensation, history of aphasia, or medication use.
When comparing the painful with the dominant sides and the nonpainful with the nondominant sides, the subjects with HSP had lower PPTs than did the control subjects who have had a stroke in the painful/dominant shoulders (mean [ Table 2 ). The men www.ajpmr.com consistently had higher thresholds than the women at all testing locations (see Figs. 1 and 2) .
Comparisons between the contralesional/ contralesional sides and the ipsilesional/ipsilesional sides of the subjects with HSP and the controls had similar results. It should be noted that the number of measurements for the ipsilesional tibialis ante-rior muscles of the 20 subjects of the HSP group is 14 because of the study design. The number of shoulder comparisons is 20 in both the contralesional and ipsilesional comparisons. The subjects with HSP had lower PPTs than did the control subjects who have had a stroke in the contralesional shoulders ( Values are presented as mean (standard deviation). P indicates painful side in HSP; NP, nonpainful side in HSP; D, dominant side in controls; ND, nondominant side in controls; CL, contralesional side (HSP and controls); IL, ipsilesional side (HSP and controls). Table 2 ). The model for predicting the difference in PPT between the painful shoulder of the HSP group and the dominant shoulder of the controls when controlling for sex was significant (adjusted r 2 = 0.33, F 1,39 = 10.8, P = 0.0002), and the predicted difference of 2.1 kg/cm 2 (95% CI, 1.8Y2.4 kg/cm 2 ) was lower for those with HSP than the controls. The model for the difference in PPT in the nonpainful shoulder compared with the nondominant shoulder was significant (adjusted r 2 = 0.24, F 1,39 = 7.0, P = 0.003), and those with HSP had a predicted PPT of FIGURE 1 PPTs (kg/cm 2 ) of those with HSP (pain) and the pain-free survivors of stroke (control) of the painful shoulder in those with HSP and the dominant shoulder in the controls (A); the nonpainful shoulder in those with HSP and the nondominant shoulder in the controls (B); and the tibialis anterior muscle of nonpainful side in those with HSP and the nondominant side in the controls (C).
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Hypersensitivity in Hemiplegic Shoulder Pain 1.5 kg/cm 2 (95% CI, 1.2Y1.9 kg/cm 2 ), lower than that of the controls. Similarly, the model for the tibialis anterior muscle on the nonpainful and the nondominant side was significant (adjusted r 2 = 0.22, F 1,39 = 6.6, P = 0.003), and those with HSP had a predicted PPT of 2.3 kg/cm 2 (95% CI, 2.2Y2.5 kg/cm 2 ), lower than that of the controls.
The model for predicting the difference in PPT between the contralesional shoulders of the HSP group and the control group when controlling for sex was significant (adjusted r 2 = 0.32, F 1,39 = 10.2, P = 0.0003), and the predicted difference of 2.1 kg/cm 2 (95% CI, 1.7Y2.3 kg/cm 2 ) was lower for those with HSP than the controls. The model for the difference in PPT in the ipsilesional shoulders was significant (adjusted r 2 = 0.25, F 1,39 = 7.6, P = 0.002), and those with HSP had a predicted PPT of 1.6 kg/cm 2 (95% CI, 1.2Y2.0 kg/cm 2 ), lower than that of the controls. Similarly, the model for the tibialis anterior muscle on the ipsilesional side was significant (adjusted r 2 = 0.21, F 1,33 = 5.4, P = 0.01), and those with HSP had a predicted PPT of 2.5 kg/cm 2 (95% CI, 2.3Y2.7 kg/cm 2 ), lower than that of the controls.
DISCUSSION
Chronic HSP affects many survivors of stroke and is often difficult to treat. The lack of knowledge of the pathogenesis of chronic HSP contributes to the challenge of developing an effective treatment. One of the factors hypothesized to play a role in chronic HSP is central sensitivity, and recent studies have provided initial evidence that those experiencing HSP have somatosensory abnormalities. 9Y11 This study provides evidence of central hypersensitivity through widespread, reduced PPTs, or a lower threshold for the experience of pain, in those with chronic HSP.
This study indicates that the subjects with chronic HSP not only have lower PPTs at their painful shoulder than do the pain-free control subjects at their dominant shoulder but also have lower PPTs at distal, pain-free sites, which provides evidence of widespread central hypersensitivity to pain. If the findings were limited to the painful shoulder, it would not be possible to discern between peripheral hypersensitivity, central hypersensitivity, or sensory abnormalities caused by a spinothalamocortical lesion. The finding that distal, pain-free sites experience pain at lower pressure levels supports that a central process may affect the perception of pain over the whole body of those with chronic HSP. Evidence of central hypersensitivity in chronic HSP suggests that new targets for treatment should be explored, those that are not attempting to ameliorate the painful response to a noxious stimulus (nociceptive pain) but instead address changes within the nervous system that result in central hypersensitivity. It has been hypothesized that electrical stimulation could be a neuromodulatory treatment that works in this manner, 8, 30 although this has not yet been shown in clinical trials.
This study is the first to show reduced PPTs in distal, nonaffected tissues of those with chronic HSP compared with the pain-free controls who have had a stroke. Roosink et al. 10 surmise a role of central hypersensitivity in HSP through observed somatosensory differences between those with HSP, pain-free survivors of stroke, and a healthy population; however, no differences were found in those with HSP and the pain-free survivors of stroke in electrical-or pressure-pain thresholds at the affected or unaffected shoulders. Greater allodynia to cold and sharpness were found when comparing ratios of the affected to unaffected arms of those with HSP and the pain-free survivors of stroke; however, it is not discernable whether these differences are related to a spinothalamocortical lesion, peripheral hypersensitivity, or central hypersensitivity. 9, 10 It is not clear why Roosink et al. 10 did not find evidence of widespread hyperalgesia to pressure-pain as the authors did in this study. The inclusion and exclusion criteria were similar, although there are a few methodological differences. Similar to this study, the study by Roosink et al. 10 analyzes interindividual comparisons to detect abnormal pressure-pain perception, although the examination sites were limited to the shoulders, whereas this study also included the tibialis anterior muscle. Roosink et al. 10 measured three separate sites on each deltoid muscle and recorded the mean, whereas the authors performed three measurements at the same site of each deltoid muscle.
Other differences exist in study design, and interpretation of findings differ from the authors' approach. In this study, the authors compared the painful and nonpainful with the dominant and nondominant, respectively, as well as compared between the contralesional sides and the ipsilesional sides, and inferred evidence of central hypersensitivity in the presence of hyperalgesia in distal, healthy tissues of those with HSP compared with the controls. In addition to direct comparison of sitespecific PPT values, Roosink et al. 10 uses intraindividual side-to-side comparisons to detect differences in PPTs and compares proportions of individuals with abnormal pressure-pain perception between groups. Recommendations for using intraindividual side-to-side comparisons on the basis that these are more sensitive to detection of sensory abnormalities 31 may not be ideal for detecting widespread hyperalgesia that is seen in central hypersensitivity. This may be more of a problem in the population that has had a stroke given the high prevalence of unilateral sensory abnormalities. 7, 12 There are limitations that should be kept in mind in this study. One main limitation of this study is the small sample size. Future studies should include larger samples because important differences may exist between subgroups that could provide further information about central hypersensitivity and HSP. A further limitation is that PPTs are indirect and subjective measures of central hypersensitivity. Although another objective, indirect measures of central hypersensitivity, has been studied in other populations, 32,33 at this time, there are no direct measures available to researchers or clinicians. The authors feel that relative PPT values can serve as a proxy for central hypersensitivity and the association with chronic pain. The evaluators in this study were also not blinded to group and, with that knowledge, have potential for introducing bias to the results. The authors attempted to diminish such bias by having the evaluators perform the PPT testing while being blinded to the pressure reading. There is evidence that psychologic measures may affect pain perception; however, psychologic information of the subjects in this study was not gathered. However, this may not be as problematic for this study, given the results of a recent study that showed that PPTs were not correlated with psychologic factors in women. 34 Other factors that could affect PPTs, such as painless diabetic neuropathy or severity of motor impairment, cannot be ruled out as potentially influencing results. Finally, this study provides no information about causality. One longitudinal study has shown lowered PPTs after onset of chronic pain, 35 although no study has replicated those results. There is also evidence that pain thresholds can predict the development of chronic pain, 36 so the direction of the relationship is not known at this time.
Further studies need to be conducted to determine appropriate interpretation of the phenomena observed here, such as a longitudinal analysis of PPTs in local and distal, healthy tissues in a population of survivors of stroke, to observe changes in PPTs relative to development and treatment of HSP. It is also important to determine ideal methods for detecting central hypersensitivity in the population that has had a stroke and within individuals. Ideally, a single test would be able to determine whether an individual was experiencing central hypersensitivity.
CONCLUSIONS
Evidence that widespread central hypersensitivity is associated with chronic HSP is evidenced by the presence of lower pain thresholds (hypersensitivity to pressure pain) in distal, healthy tissues when compared with the control subjects. Further exploration into the role of central hypersensitivity in HSP should be undertaken. The results of this study may be useful in creating more effective and easy-to-use treatments for HSP. The answers to any essay questions must be typed or computer printed on a separate piece of paper and attached to this page. After finishing this exam: 1. Check your answers with the correct answers on page 83.
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